Literature DB >> 17135305

Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Massimo Cazzaniga1, Francesco Salerno, Giovanni Pagnozzi, Elena Dionigi, Stefania Visentin, Ilaria Cirello, Daniele Meregaglia, Antonio Nicolini.   

Abstract

BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) is a treatment for portal hypertension-related complications. Accurate prediction of the outcome of patients treated with TIPS is important, because some patients have very short survival. Diastolic dysfunction is frequently observed in patients with cirrhosis. AIM: To investigate whether or not diastolic dysfunction can predict the outcome after TIPS.
METHODS: Echocardiography with Doppler exploration was performed before and 28 days after TIPS insertion in 32 patients with cirrhosis. Several echocardiographic measures, including the early maximal ventricular filling velocity/late filling velocity (E/A) ratio as indicative of diastolic function, as well as laboratory, clinical and demographic variables were evaluated as predictors of survival.
RESULTS: Univariate analysis revealed that the presence of diastolic dysfunction observed 28 days after TIPS (E/A ratio </=1) and baseline model of end-stage liver disease score were related to survival. Multivariate analysis identified diastolic dysfunction as an independent predictor of death (RR 8.9, 95% CI 1.9 to 41.5, p = 0.005). During the first year of follow-up, six out of 10 patients with an E/A ratio </=1 died, whereas all 22 patients with E/A ratio >1 survived.
CONCLUSIONS: Diastolic dysfunction estimated using E/A ratio is a promising predictor of death in patients with cirrhosis who are treated with TIPS.

Entities:  

Mesh:

Year:  2006        PMID: 17135305      PMCID: PMC1954837          DOI: 10.1136/gut.2006.102467

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

Review 2.  Determinants of left ventricular filling and of the diastolic pressure-volume relation.

Authors:  J C Gilbert; S A Glantz
Journal:  Circ Res       Date:  1989-05       Impact factor: 17.367

3.  Left ventricular interaction with arterial load studied in isolated canine ventricle.

Authors:  K Sunagawa; W L Maughan; D Burkhoff; K Sagawa
Journal:  Am J Physiol       Date:  1983-11

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

5.  Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.

Authors:  W L Henry; A DeMaria; R Gramiak; D L King; J A Kisslo; R L Popp; D J Sahn; N B Schiller; A Tajik; L E Teichholz; A E Weyman
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

6.  Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.

Authors:  F Salerno; S Badalamenti; P Moser; E Lorenzano; P Incerti; N Dioguardi
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

7.  High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting.

Authors:  A C Braverman; M A Steiner; D Picus; H White
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

Review 8.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Authors:  V Arroyo; P Ginès; A L Gerbes; F J Dudley; P Gentilini; G Laffi; T B Reynolds; H Ring-Larsen; J Schölmerich
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

9.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

10.  Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume.

Authors:  Francesco Salerno; Massimo Cazzaniga; Giovanni Pagnozzi; Ilaria Cirello; Antonio Nicolini; Daniele Meregaglia; Larry Burdick
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  53 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Does cirrhotic cardiomyopathy exist? 50 years of uncertainty.

Authors:  Pierpaolo Pellicori; Concetta Torromeo; Angela Calicchia; Alessandra Ruffa; Martina Di Iorio; John G F Cleland; Manuela Merli
Journal:  Clin Res Cardiol       Date:  2013-09-01       Impact factor: 5.460

Review 3.  Cardiovascular determinants of survival in cirrhosis.

Authors:  Samuel S Lee; Hongqun Liu
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

4.  The impact of left ventricular hypertrophy on survival in candidates for liver transplantation.

Authors:  Sachin Batra; Victor I Machicao; John S Bynon; Shivang Mehta; Rajasekhar Tanikella; Michael J Krowka; Steven Zacks; James Trotter; Kari E Roberts; Robert S Brown; Steven M Kawut; Michael B Fallon
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

Review 5.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

6.  Assessment of diastolic function in the management of patients with cirrhosis.

Authors:  Søren Møller
Journal:  Hepatol Int       Date:  2014-07-27       Impact factor: 6.047

Review 7.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

8.  Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Milind Phadke; Krantikumar Rathod; Megha Meshram; S J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-01-24

Review 9.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 10.  Recent advances in cirrhotic cardiomyopathy.

Authors:  Dimitrios S Karagiannakis; George Papatheodoridis; Jiannis Vlachogiannakos
Journal:  Dig Dis Sci       Date:  2014-11-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.